Biohaven BHVN 深 沪
已收盘 10-09 16:00:00 美东时间
12.08
+0.150
+1.26%
华盛通- 最 高12.27
- 今 开11.90
- 成交量 137.01万股
- 最 低 11.745
- 昨 收 11.93
- 总市值 18.25亿
- 52周最高 18.5657
- 市盈率 静 --
- 换手率 0.91%
- 52周最低 7.48
- 委 比 20.00%
- 总股本 1.51亿
- 历史最高 152.56
- 量 比 0.61
- 振 幅 4.40%
- 历史最低 7.10
- 每 手 1
- 风险率 2.54%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biohaven licenses IgG degrader portfolio to Japan’s Ono
Biohaven (BHVN) on Thursday announced an agreement with Ono Pharmaceutical (OPHLF) (OPHLY) under which the Japanese drugmaker will develop and commercialize the company’s MoDE pan IgG degrader portfol...
10-08 22:13
Biohaven To Present Data On BHV-1530, FGFR3-Directed ADC Using Topoisomerase I Payload, At 38th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics
Oral presentation selected: Phase 1 findings from the ongoing BHV1530-101 study will be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2026), a leading international forum for early-phase oncology drug development. First-in-cla...
09-28 19:49
美股前瞻 | 巴菲特官宣“谢幕”！正式卸任伯克希尔董事长；三巫日波动警告，美股今夜迎流动性考验
三巫日波动警告！美股今夜迎流动性考验；Strategy盘前再升3%，小摩坚定看涨比特币潜力超黄金；巴菲特“谢幕”！官宣卸任伯克希尔董事长>>
09-18 20:33
Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 150 points on Friday. Shares of Xenon Pharmaceuticals Inc (NASDAQ:XENE) fell sharply in pre-market trading after the company announced a temporary pause in enrollment for new patients in its ongoing psychiatry st...
09-18 20:01
期权扫描 | AI多头集体出手！英特尔、AMD、美光Call单飙涨逾400%；CoreWeave期权成交环比激增逾2倍
AI多头集体出手！英特尔、AMD、美光Call单飙涨逾400%；CoreWeave融资再加码，期权成交环比激增逾2倍>>
09-18 17:57
Analysts Are Bullish on Top Healthcare Stocks: Biohaven Ltd. (BHVN), Boston Scientific (BSX)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-14 18:20
Biohaven Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Biohaven (BHVN)
Biohaven shares gave up nearly 15% in a single session on September 10, 2026 following the FDA's partial clinical hold on new-patient enrollment in the BHV-7000/opakalim epilepsy trials NEW ...
09-12 06:28
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
FDA Pauses New Enrollment for Biohaven Epilepsy Drug Program
Biohaven Ltd. (NYSE:BHVN) on Thursday announced a partial clinical hold issued by the U.S. Food and Drug Administration (FDA) on new patient enrollment for its BHV-7000 program, while maintaining timelines for its lead pivotal study in refractory focal epilepsy. FDA Issued Partial Hold On New Enroll...
09-10 22:43
美股大行评级 | 多家大行齐上调Robinhood目标价！最高看至150美元；安进股价大跌后评级遭下调
今日重点评级关注：Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.3美元升至8.45美元；摩根大通：维持Vera Therapeutics"超配"评级，目标价从76美元升至83美元
09-09 15:36
